Akt-mediated survival of oligodendrocytes induced by neuregulins

Journal of Neuroscience

Volumn 20, Issue 20, 2000, Pages 7622-7630

  Flores, A I ^a   Mallon, B S ^a   Matsui, T ^a   Ogawa, W ^a   Rosenzweig, A ^a   Okamoto, T ^a   Macklin, W B ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Akt; Apoptosis; Multiple sclerosis; Neuregulin; Oligodendrocyte; Survival

Indexed keywords

CASPASE; NEU DIFFERENTIATION FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN TYROSINE KINASE; WORTMANNIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL SURVIVAL; ENZYME ACTIVATION; GLIOMA CELL; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

EID: 0034667559     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.20-20-07622.2000     Document Type: Article

References (74)

1. Role of translocation in the activation and function of protein kinase B
2. Proliferation of human Schwann cells induced by neu differentiation factor isoforms
3. Cell death and control of cell survival in the oligodendrocyte lineage
4. BAD enables ceramide to signal apoptosis via Ras and Raf-1
5. Neuregulins and their receptors: A versatile signaling module in organogenesis and oncogenesis
6. The neuregulin, glial growth factor 2, diminishes autoimmune demyelination and enhances remyelination in a chronic relapsing model for multiple sclerosis
7. GGF/neuregulin is a neuronal signal that promotes the proliferation and survival and inhibits the differentiation of oligodendrocyte progenitors
8. GGF/Neuregulin induces a phenotypic reversion of oligodendrocytes
9. Regulation of cell death protease caspase-9 by phosphorylation
10. Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinases
11. Ligands for ErbB-family receptors encoded by a neuregulin-like gene
12. Expression of multiple neuregulin transcripts in postnatal rat brains
13. Differential signaling by the epidermal growth factor-like growth factors neuregulin-1 and neuregulin-2
14. Early and late neuropathological changes in perinatal white matter damage
15. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
16. Oligodendroglial survival factors, PDGF-AA, and CNTF, activate similar JAK/STAT signaling pathways
17. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt
18. Regulation of neuronal survival by the serine-threonine kinase Akt
19. PTEN mutations in gliomas and glioneuronal tumors
20. Monoclonal antibody to a plasma membrane antigen of neurons
21. ErbB3 is required for normal cerebellar and cardiac development: A comparison with ErbB2- and heregulin-deficient mice
22. Neuregulins and erbB receptors in cultured neonatal astrocytes
23. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase
24. PI3K: Downstream AKTion blocks apoptosis
25. Phosphodiesterase I, a novel adhesion molecule and/or cytokine involved in oligodendrocyte function
26. Defects in path-finding by cranial neural crest cells in mice lacking the neuregulin receptor ErbB4
27. Oligodendrocyte apoptosis mediated by caspase activation
28. Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC
29. Neuregulin-4: A novel growth factor that acts through the ErbB-4 receptor tyrosine kinase
30. ICE/CED-3 family executes oligodendrocyte apoptosis by tumor necrosis factor
31. Targeted expression of baculovirus p35 caspase inhibitor in oligodendrocytes protects mice against autoimmune-mediated demyelination
32. The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal
33. Requirement for activation of the serine-threonine kinase Akt (protein kinase B) in insulin stimulation of protein synthesis but not of glucose transport
34. Neuregulins with an Ig-like domain are essential for mouse myocardial and neuronal development
35. Regulation of phosphorylation of the c-erbB-2/HER2 gene product by a monoclonal antibody and serum growth factor(s) in human mammary carcinoma cells
36. Neuregulins in development
37. A family of putative tumor suppressors is structurally and functionally conserved in humans and yeast
38. Allelic deletion analyses of MMAC/PTEN and DMBT1 loci in gliomas: Relationship to prognostic significance
39. Aberrant development of motor axons and neuromuscular synapses in erbB2-deficient mice
40. Heregulin regulation of Akt/protein kinase B in breast cancer cells
41. CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death
42. Regulation of experimental autoimmune encephalomyelitis with insulin-like growth factor (IGF-1) and IGF-1/IGF-binding protein-3 complex (IGF-1/IGFBP3)
43. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate
44. Neuregulin in neuron/glial interactions in the central nervous system. GGF2 diminishes autoimmune demyelination, promotes oligodendrocyte progenitor expansion and enhances remyelination
45. ErbB-3 mediated differential mitogenic effects of NDF/heregulin isoforms on mouse keratinocytes
46. Are there indicators of remyelination in blood or CSF of multiple sclerosis patients?
47. Cerebrospinal-fluid ciliary neurotrophic factor in neurological patients
48. Adenoviral gene transfer of activated phosphatidylinositol 3'-kinase and Akt inhibits apoptosis of hypoxic cardiomyocytes in vitro
49. Ciliary neurotrophic factor and leukemia inhibitory factor promote the generation, maturation and survival of oligodendrocytes in vitro
50. Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity
51. Distinct isoforms of neuregulin are expressed in mesenchymal and neuronal cells during mouse development
52. Multiple essential functions of neuregulin in development
53. Isoform-specific expression and function of neuregulin
54. Patterns of oligodendrocyte pathology in multiple sclerosis
55. Expression of the c-erbB-3 protein in normal human adult and fetal tissues
56. Neonatal oligodendrocytes contain and secrete neuregulins in vitro
57. Effect of neu differentiation factor isoforms on neonatal oligodendrocyte function
58. Programmed cell death and the control of cell survival: Lessons from the nervous system
59. On the immunopathology of plaque development and repair in multiple sclerosis
60. Phosphatidylinositol 3-kinase links the interleukih-2 receptor to protein kinase B and p70 S6 kinase
61. Severe neuropathies in mice with targeted mutations in the ErbB3 receptor
62. Expression of oligodendrocyte progenitor cell antigens by gliomas: Implications for the histogenesis of brain tumors
63. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN
64. Caspases: Enemies within
65. Two models for multiple sclerosis: Experimental allergic encephalomyelitis and Theiler's murine encephalomyelitis virus
66. Axonal neuregulin signals cells of the oligodendrocyte lineage through activation of HER4 and Schwann cells through HER2 and HER3
67. Failure of spinal cord oligodendrocyte development in mice lacking neuregulin
68. Oligodendrocytes and their precursors require phosphatidylinositol 3-kinase signaling for survival
69. Growth factors and myelin regeneration in multiple sclerosis
70. Cysteine-rich domain isoforms of the neuregulin-1 gene are required for maintenance of peripheral synapses
71. Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells
72. Insulin-like growth factor I treatment reduces demyelination and up-regulates gene expression of myelin-related proteins in experimental autoimmune encephalomyelitis
73. Apoptosis occurs in the oligodendroglial lineage, and in prevented by basic fibroblast growth factor
74. Neuregulin-3 (NRG3): A novel neural tissue-enriched protein that binds and activates ErbB4